Mammalian RNAs can be edited by the conversion of adenosine to inosine, which is read as guanosine, but technological constraints have limited our view of the overall contribution of RNA editing ...

Editing RNA isn’t all that different from DNA base-editing techniques, which typically use Cas9 or other enzymes attached to a CRISPR guide RNA to replace one nucleotide with another. In the case of ...

Through international collaboration, researchers at KAIST have revealed that RNA editing plays a crucial role in regulating neuroinflammation, a key pathology of Parkinson's disease. The paper is ...

Rznomics Inc. scored a potential ₩1.9 trillion (US$1.35 billion) global license option agreement with Eli Lilly and Co. to ...

Recent research from the Korea Advanced Institute of Science and Technology (KAIST) reveals that RNA editing plays a role in modulating neuroinflammation, a critical factor in the disease's ...

Through international collaboration, researchers at KAIST have revealed that RNA editing plays a crucial role in regulating neuroinflammation, a key pathology of Parkinson's disease. KAIST ...

The agreement focuses on developing and commercializing RNA-editing therapies using Rznomics’ proprietary trans-splicing ribozyme platform. Also Read: Eli Lilly Stock Offers Buying Opportunity ...